The nature of inhibition of steroid sulphatase activity by tibolone and its metabolites

Modelska, 2002, Tibolone for postmenopausal women: systematic review of randomised trials, J. Clin. Endocrinol. Metab., 87, 16, 10.1210/jc.87.1.16 Albertazzi, 1989, Tibolone: a review, Maturitas, 30, 295, 10.1016/S0378-5122(98)00059-0 Kloosterboer, 2000, Intracrinology: the secret of the tissue-specificity of tibolone, J. Br. Menopause Soc., 6, 23 Markiewicz, 1990, In vitro evaluation of estrogenic, estrogen antagonistic and progestagenic effects of a steroidal drug (Org OD14) and its metabolites on human endometrium, J. Steroid Biochem., 35, 535, 10.1016/0022-4731(90)90196-Y Reed, 2004, Tibolone: a selective tissue estrogenic activity regulator (STEAR), Maturitas, 48, S4, 10.1016/j.maturitas.2004.02.013 Reed, 2004, Role of enzymes and tissue-specific actions of steroids, Maturitas, 48, S18, 10.1016/j.maturitas.2004.03.007 Tang, 1993, Human endometrial 3β-hydroxysteroid dehydrogenase/isomerase can locally reduce intrinsic estrogenic/progestogenic activity ratios of a steroidal drug (Org 14), J. Steroid Biochem. Mol. Biol., 45, 345, 10.1016/0960-0760(93)90003-F Valdivia, 2000, Mammographic density in postmenopausal women treated with tibolone, estriol or conventional hormone replacement therapy, Clin. Drug Invest., 20, 101, 10.2165/00044011-200020020-00005 Moore, 1999, Livial: a review of clinical studies, Br. J. Obstet. Gynaecol., 106, 1 Chetrite, 1997, Effect of tibolone (Org OD14) and its metabolites on estrone sulphatase activity in MCF-7 and T-47D mammary cancer cells, Anticancer Res., 17, 135 Purohit, 2002, Inhibition of oestrone sulphatase activity by tibolone and its metabolites, Horm. Metab. Res., 34, 1, 10.1055/s-2002-19958 Miki, 2002, Systemic distribution of steroid sulfatase and estrogen sulfotransferase in human adult and fetal tissues, J. Clin. Endocrinol. Metab., 87, 5760, 10.1210/jc.2002-020670 Miyoshi, 2003, High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer, Clin. Cancer Res., 9, 2288 Bonney, 1983, The relationship between 17β-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue, Clin. Endocrinol., 19, 727, 10.1111/j.1365-2265.1983.tb00051.x Reed, 1996, The development of steroid sulphatase inhibitors, Endocr. Relat. Cancer, 3, 9, 10.1677/erc.0.0030009 Delbressine, 2000, Sulphated metabolites of tibolone show sulphatase inhibiting activity, Prog. ENDO, 396 Howarth, 1994, Estrone sulfamates: potent inhibitors of estrone sulfatase activity with therapeutic potential, J. Med. Chem., 37, 219, 10.1021/jm00028a002 Duncan, 1993, Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate – a potential therapeutic agent in breast cancer, Cancer Res., 53, 298 Purohit, 1992, Oestrogen sulphatase activity in hormone-dependent breast cancer cells: modulation by steroidal and non-steroidal therapeutic agents, Int. J. Cancer, 50, 901, 10.1002/ijc.2910500614 Purohit, 1995, Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate, Biochemistry, 34, 11508, 10.1021/bi00036a025 Kloosterboer, 2001, Tibolone: a steroid with a tissue-specific mode of action, J. Steroid Biochem. Mol. Biol., 76, 231, 10.1016/S0960-0760(01)00044-9 Chetrite, 1999, Effects of Org OD14 (Livial) and its metabolties on 17β-hydroxysteroid dehydrogenase activity in hormone-dependent MCF-7 and T-47D breast cancer cells, Anticancer Res., 19, 261 Chetrite, 1999, Effect of Org OD14 (Livial) and its metabolites on hormone-dependent MCF-7 and T-47D, and hormone-independent MDA-MB-231 breast cancer cell lines, Anticancer Res., 19, 269 Nakata, 2003, Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients, J. Steroid Biochem. Mol. Biol., 86, 455, 10.1016/S0960-0760(03)00357-1 J. Desreux, H.J. Kloosterboer, A. Noel, F. Frankenne, M. Lemaire, J.M. Foidart, Effects of tibolone (Org OD14) on steroid sulfatase activity and growth of MCF-7 human breast tumors implanted in ovariectomised nude mice, in press. De Gooyer, 2001, Tibolone: a compound with tissue specific inhibitory effects on sulfatase, Mol. Cell Endocrinol., 183, 55, 10.1016/S0303-7207(01)00606-2 Hobkirk, 1993, Steroid sulfation, Trends Endocrinol. Metab., 4, 69, 10.1016/S1043-2760(05)80018-9 Falany, 2004, Sulfation of tibolone metabolites by expressed human cytosolic sulfotransferases, J. Steroid Biochem. Mol. Biol., 88, 383, 10.1016/j.jsbmb.2004.01.005 Raeside, 2000, Estradiol-17β sulfotransferase activity in canine osteosarcoma D17 cells, Biochem. Biophys. Res. Comm., 273, 505, 10.1006/bbrc.2000.2984